Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2025 08:00 ET | Source: CYTOMED THERAPEUTICS LIMITED

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...
November 18, 2025 04:00 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies...
November 17, 2025 10:48 ET | Source: 24/7 Market News

Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open

Biotech stock market news
November 17, 2025 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

“Our first quarter delivered meaningful progress across clinical, financial, and strategic initiatives,” said James Nathanielsz, CEO of Propanc.
November 17, 2025 08:00 ET | Source: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor...
November 17, 2025 07:00 ET | Source: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le quatrième trimestre de l'exercice 2025 et l'exercice 2025 le 24 novembre 2025 et fournit une mise à jour du conseil d’administration

MONTRÉAL, 17 nov. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), producteur verticalement intégré...
November 17, 2025 07:00 ET | Source: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

Cannara Biotech to report Q4 and FY2025 results November 24, 2025 at 7:00 AM, and announces with sadness the passing of longtime board member Jack M. Kay.
November 14, 2025 07:00 ET | Source: Marker Therapeutics

Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractory B-cell lymphoma MT-601 demonstrated 66% objective response rate with 50% complete response in...
November 13, 2025 08:00 ET | Source: Gate Bioscience

Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

Gate Bioscience closes $65M Series B to advance molecular gates, oral drugs that eliminate disease proteins, into clinical trials for CNS/inflammation
November 13, 2025 08:00 ET | Source: Genosafe

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes, France, November 16th, 2025...